Literature DB >> 7564711

Genetic diversity and HIV detection by polymerase chain reaction.

I Loussert-Ajaka, D Descamps, F Simon, F Brun-Vézinet, M Ekwalanga, S Saragosti.   

Abstract

Entities:  

Mesh:

Year:  1995        PMID: 7564711     DOI: 10.1016/s0140-6736(95)92762-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  14 in total

1.  Development and evaluation of a DNA enzyme immunoassay method for env genotyping of subtypes A through G of human immunodeficiency virus type 1 group M, with discrimination of the circulating recombinant forms CRF01_AE and CRF02_AG.

Authors:  Jean-Christophe Plantier; Laurence Vergne; Florence Damond; Souleymane MBoup; Eitel MPoudi-NGole; Laurence Buzelay; Isabelle Farfara; Denys Brand; Martine Peeters; Françoise Brun-Vézinet; Eric Delaporte; Francis Barin
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

2.  Performance of a multiplex qualitative PCR LCx assay for detection of human immunodeficiency virus type 1 (HIV-1) group M subtypes, group O, and HIV-2.

Authors:  K Abravaya; C Esping; R Hoenle; J Gorzowski; R Perry; P Kroeger; J Robinson; R Flanders
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

3.  Susceptibility of human immunodeficiency virus type 1 group O isolates to antiretroviral agents: in vitro phenotypic and genotypic analyses.

Authors:  D Descamps; G Collin; F Letourneur; C Apetrei; F Damond; I Loussert-Ajaka; F Simon; S Saragosti; F Brun-Vézinet
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

4.  Comparative performance of three viral load assays on human immunodeficiency virus type 1 (HIV-1) isolates representing group M (subtypes A to G) and group O: LCx HIV RNA quantitative, AMPLICOR HIV-1 MONITOR version 1.5, and Quantiplex HIV-1 RNA version 3.0.

Authors:  P Swanson; V Soriano; S G Devare; J Hackett
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

5.  Discrimination of subtype B and non-subtype B strains of human immunodeficiency virus type 1 by serotyping: correlation with genotyping.

Authors:  G Murphy; F J Belda; C P Pau; J P Clewley; J V Parry
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

6.  Characterization of a highly replicative intergroup M/O human immunodeficiency virus type 1 recombinant isolated from a Cameroonian patient.

Authors:  M Peeters; F Liegeois; N Torimiro; A Bourgeois; E Mpoudi; L Vergne; E Saman; E Delaporte; S Saragosti
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

7.  Detection of phylogenetically diverse human immunodeficiency virus type 1 groups M and O from plasma by using highly sensitive and specific generic primers.

Authors:  C Yang; D Pieniazek; S M Owen; C Fridlund; J Nkengasong; T D Mastro; M A Rayfield; R Downing; B Biryawaho; A Tanuri; L Zekeng; G van der Groen; F Gao; R B Lal
Journal:  J Clin Microbiol       Date:  1999-08       Impact factor: 5.948

8.  Design and evaluation of a human immunodeficiency virus type 1 RNA assay using nucleic acid sequence-based amplification technology able to quantify both group M and O viruses by using the long terminal repeat as target.

Authors:  M P de Baar; A M van der Schoot; J Goudsmit; F Jacobs; R Ehren; K H van der Horn; P Oudshoorn; F de Wolf; A de Ronde
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

9.  Efficiencies of four versions of the AMPLICOR HIV-1 MONITOR test for quantification of different subtypes of human immunodeficiency virus type 1.

Authors:  K Triques; J Coste; J L Perret; C Segarra; E Mpoudi; J Reynes; E Delaporte; A Butcher; K Dreyer; S Herman; J Spadoro; M Peeters
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

10.  Analysis of pol gene heterogeneity, viral quasispecies, and drug resistance in individuals infected with group O strains of human immunodeficiency virus type 1.

Authors:  M E Quiñones-Mateu; J L Albright; A Mas; V Soriano; E J Arts
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.